PRECIGEN, INC. Net Income (Loss) Attributable to Noncontrolling Interest
PRECIGEN, INC. (PGEN) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2022-03-01
- PRECIGEN, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2020-12-31 was $0.00.
- PRECIGEN, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2020-09-30 was $0.00.
- PRECIGEN, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2020-06-30 was $0.00.
- PRECIGEN, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2020-03-31 was $0.00.
- PRECIGEN, INC. net income (loss) attributable to noncontrolling interest for fiscal 2021 was $0.00.
- PRECIGEN, INC. net income (loss) attributable to noncontrolling interest for fiscal 2020 was $0.00.
- PRECIGEN, INC. net income (loss) attributable to noncontrolling interest for fiscal 2019 was -$1.59M.
- PRECIGEN, INC. net income (loss) attributable to noncontrolling interest for fiscal 2018 was -$5.37M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 | |||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 | ||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | -$165.00K derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | -$165.00K derived: sum of 3 quarters · filed 2022-03-01 | -$1.59M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-09 | -$165.00K derived: sum of 2 quarters · filed 2020-11-09 | -$1.59M 10-Q · filed 2020-11-09 | -$2.85M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | -$165.00K 10-Q · filed 2020-08-10 | -$1.59M 10-Q · filed 2020-08-10 | -$2.85M derived: sum of 3 quarters · filed 2021-03-01 | -$4.27M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | -$1.43M 10-Q · filed 2020-05-11 | -$2.68M derived: sum of 2 quarters · filed 2021-03-01 | -$4.11M derived: sum of 3 quarters · filed 2021-03-01 | -$5.55M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$2.68M derived: sum of 2 quarters · filed 2021-03-01 | -$4.13M derived: sum of 3 quarters · filed 2021-03-01 | -$5.37M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | -$1.42M 10-Q · filed 2019-11-12 | -$2.87M derived: sum of 2 quarters · filed 2019-11-12 | -$4.11M 10-Q · filed 2019-11-12 | -$10.79M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | -$1.45M 10-Q · filed 2019-08-09 | -$2.69M 10-Q · filed 2019-08-09 | -$9.37M derived: sum of 3 quarters · filed 2020-03-02 | -$10.52M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | -$1.24M 10-Q · filed 2019-05-09 | -$7.92M derived: sum of 2 quarters · filed 2020-03-02 | -$9.07M derived: sum of 3 quarters · filed 2020-03-02 | -$10.07M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | -$6.68M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$7.83M derived: sum of 2 quarters · filed 2020-03-02 | -$8.82M derived: sum of 3 quarters · filed 2020-03-02 | -$9.80M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | -$1.15M 10-Q · filed 2018-11-08 | -$2.15M derived: sum of 2 quarters · filed 2018-11-08 | -$3.12M 10-Q · filed 2018-11-08 | -$3.90M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | -$998.00K 10-Q · filed 2018-08-13 | -$1.98M 10-Q · filed 2018-08-13 | -$2.75M derived: sum of 3 quarters · filed 2019-03-01 | -$3.78M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | -$978.00K 10-Q/A · filed 2018-08-13 | -$1.75M derived: sum of 2 quarters · filed 2019-03-01 | -$2.78M derived: sum of 3 quarters · filed 2019-03-01 | -$3.75M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2016-12-31 | -$775.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$1.80M derived: sum of 2 quarters · filed 2019-03-01 | -$2.77M derived: sum of 3 quarters · filed 2019-03-01 | -$3.66M 10-K · filed 2019-03-01 | ||
| 2016-09-30 | -$1.03M 10-Q · filed 2017-11-09 | -$2.00M derived: sum of 2 quarters · filed 2017-11-09 | -$2.89M 10-Q · filed 2017-11-09 | -$3.45M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-06-30 | -$967.00K 10-Q · filed 2017-08-09 | -$1.86M 10-Q · filed 2017-08-09 | -$2.42M derived: sum of 3 quarters · filed 2018-03-01 | -$3.23M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-03-31 | -$891.00K 10-Q · filed 2017-05-10 | -$1.45M derived: sum of 2 quarters · filed 2018-03-01 | -$2.27M derived: sum of 3 quarters · filed 2018-03-01 | -$3.10M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | -$561.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$1.38M derived: sum of 2 quarters · filed 2018-03-01 | -$2.21M derived: sum of 3 quarters · filed 2018-03-01 | -$3.50M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | -$816.00K 10-Q · filed 2016-11-09 | -$1.65M derived: sum of 2 quarters · filed 2016-11-09 | -$2.94M 10-Q · filed 2016-11-09 | -$3.84M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | -$831.00K 10-Q · filed 2016-08-09 | -$2.12M 10-Q · filed 2016-08-09 | -$3.02M derived: sum of 3 quarters · filed 2017-03-01 | -$4.16M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | -$1.29M 10-Q · filed 2016-05-10 | -$2.19M derived: sum of 2 quarters · filed 2017-03-01 | -$3.33M derived: sum of 3 quarters · filed 2017-03-01 | -$4.22M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | -$899.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$2.04M derived: sum of 2 quarters · filed 2017-03-01 | -$2.93M derived: sum of 3 quarters · filed 2017-03-01 | -$3.79M 10-K · filed 2017-03-01 | ||
| 2014-09-30 | -$1.14M 10-Q · filed 2015-11-09 | -$2.03M derived: sum of 2 quarters · filed 2015-11-09 | -$2.90M 10-Q · filed 2015-11-09 | -$3.71M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | -$892.00K 10-Q · filed 2015-08-10 | -$1.76M 10-Q · filed 2015-08-10 | -$2.57M derived: sum of 3 quarters · filed 2016-02-29 | -$3.02M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | -$866.00K 10-Q · filed 2015-05-11 | -$1.68M derived: sum of 2 quarters · filed 2016-02-29 | -$2.13M derived: sum of 3 quarters · filed 2016-02-29 | -$2.69M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | -$814.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$1.26M derived: sum of 2 quarters · filed 2016-02-29 | -$1.82M derived: sum of 3 quarters · filed 2016-02-29 | -$1.93M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | -$507.00K 10-Q · filed 2014-11-13 | -$1.00M derived: sum of 2 quarters · filed 2014-08-14 | -$1.11M 10-Q · filed 2014-11-13 | |||
| 2013-06-30 | -$556.00K 10-Q · filed 2014-08-14 | -$507.00K 10-Q/A · filed 2013-10-21 | -$607.00K 10-Q · filed 2014-08-14 | -$558.00K 10-Q/A · filed 2013-10-21 | ||
| 2013-03-31 | -$51.00K 10-Q · filed 2014-05-09 | |||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |